Fundraising FoxThousand Oaks · Seed–Late Stage · 2 people tracked
Also known as Amgen
Find your way into Amgen Ventures
Sign up to see every warm intro you have to Amgen Ventures
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Amgen Ventures team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Through its Start-Up Network Program, Amgen sponsors life sciences incubators in key biotech innovation clusters and, in alignment with Amgen Ventures, provides funding and scientific support to early-stage life sciences and biotech start-ups. Since 2015 the program has supported over 20 companies, offering mentoring, scientific interaction, networking, potential collaboration, and access to innovation within the incubator community through a competitive selection process.
Source: firm website, verified Aug 3, 2026.
Team · 2 people
from curated & public directories
What they invest in
from 28 of 32 portfolio companiesBiotech ×21Healthtech ×16Deep Tech ×10Medical Devices ×9AI & Machine Learning ×8Digital Health ×6Logistics & Supply Chain ×2Advanced Manufacturing ×1
HQs:United States×26
Investments · 32 tracked
founders shown can be your intro pathBy year:2026 · 22025 · 32024 · 32023 · 32022 · 52021 · 52020 · 22019 · 22009 · 126 dated
BIOAGE develops therapies targeting the molecular pathways that drive aging to increase healthspan and address age-related chronic diseases.
BiotechHealthtechLongevityRichmond, US
Kristen Fortney, PhD(Co-Founder, CEO)Eric Morgen, MD(Co-Founder, COO)Kristen Fortney(Founder)inEric Morgen(Founder)inDov Goldstein(Executive Officer)in
BoardPatrick Enright(Director)in
Co-investorsAndreessen HorowitzElad GilFelicis VenturesGreen Sands EquityIA Seed VenturesLongitude Capital+19 more
Generate:Biomedicines develops protein-based therapeutics using artificial intelligence and machine learning in a field it calls Generative Biology, combining computational protein design with biological engineering.
AI & Machine LearningBiotechDeep TechSomerville, US
Gevorg Grigoryan(Founder)inMichael Nally(Chief Executive Officer)inAvak Kahvejian(Founder)Geoffrey von Maltzahn(Founder)Molly Gibson(Founder)
Co-investorsFlagship PioneeringAlumni VenturesARCH Venture PartnersMarch Capital PartnersAlaska Permanent Fund CorporationALTITUDE LIFE SCIENCE VENTURES+3 more
Neumora is a clinical research company developing investigational medications, with a focus on conducting clinical trials to obtain regulatory approval and make treatments available to patients.
BiotechDeep TechDigital HealthMedical DevicesWatertown, US
Paul L. Berns(Chairman and Chief Executive Officer)Joshua Pinto(Executive Officer)Tamara Tompkins(Executive Officer)inKari Stefansson(Director)Maykin Ho(Director)Alaa Halawa(Director)
Co-investorsARCH Venture PartnersCatalio Capital Management, LPF-Prime CapitalK2 HealthVenturesMercury FundPremier Partners+12 more
Nkarta is a biotech company developing allogeneic CAR NK cell therapies for autoimmune diseases, aiming to offer safer and more accessible alternatives to autologous CAR-T treatments.
BiotechHealthtechSouth San Francisco, US
Paul Hastings(Executive Officer, Director)inPaul H.inMatthew Plunkett(Executive Officer)in
BoardMichael Dybbs(Director)Jill Carroll(Director)inTiba Aynechi(Director)in
Co-investorsNew Enterprise Associates (NEA)RA CapitalSamsara BioCapitalSR One Capital ManagementLogosNorwest Venture Partners+1 more
Senti Bio develops cell and gene therapies for cancer and difficult-to-treat diseases using synthetic biology and engineered Gene Circuits to enhance precision, control, and selectivity in targeting tumor cells.
BiotechDeep TechMedical DevicesSouth San Francisco, US
Tim Lu(Co-Founder and Chief Executive Officer)inPhilip Lee(Executive Officer)inKanya Rajangam(President, Head of Research & Development and Chief Medical Officer)inYvonne Li(Executive Officer)inJames Collins(Director)Timothy Lu(Founder)
Co-investorsEvolution VC PartnersFlucas VenturesGreen Sands EquityLifeforce CapitalLifeSci Venture PartnersLux Capital+12 more
The Amgen Foundation funds and runs science education programs, providing teachers with research equipment and training and offering hands-on and virtual learning opportunities to students and scholars.
BiotechEdTechImpact & Social Good
Big Hat Bio develops therapeutics under development across multiple programs.
AI & Machine LearningBiotechDeep TechSan Francisco, US
Peyton Greenside(Founder)inMark DePristo(Founder)inMark DePristo Peyton Greenside(Founder)Theresa Tribble(Founder)
BoardFrancisco Gimenez(Director)inSteve Kafka(Director)
Co-investors8VCAndreessen HorowitzBOLD LongevityFlucas VenturesGRIDS CapitalIntermountain Health+12 more
Calistoga Pharmaceuticals is a pharmaceutical company.
BiotechHealthtechSeattle, US
Co-investorsFrazier Life SciencesAlta PartnersFrazier Healthcare Partners
Cartography develops antibody-based cancer therapies using single-cell sequencing and computational biology to identify precise cellular targets.
AI & Machine LearningBiotechDeep TechMedical DevicesSouth San Francisco, US
Max Mumbach(Founding Scientist, Target Discovery)inJeffrey Verboon(Founding Scientist, Computational Biology)inAnsu Satpathy(Founder)Kevin Parker, PhD(Chief Executive Officer, Board Director; co-founder)Ansuman Satpathy, MD, PhD(Co-founder; Board Director)Howard Chang(Founder)in
Co-investors8VCAndreessen HorowitzArtis VenturesCatalio Capital Management, LPFinchley Healthcare VenturesGlobal BioAccess Fund+9 more
CatenaBio develops precision conjugation technology using native amino acids to enable biotherapeutic fusions of small molecules, nucleic acids, enzymes, and cells.
BiotechDeep TechHealthtechMedical DevicesBerkeley, US
Marco Lobba(Founder)inMatthew Francis(Founder)inGeo Guillen
Co-investorsCalifornia Innovation FundCivilization Ventures Management, LlcCreative Destruction Lab (CDL)FREEFLOWIaso VenturesJude Gomila+14 more
Code Biotherapeutics develops a proprietary non-viral 3DNA delivery platform for genetic medicines, RNAi, and other modalities, using targeting molecules to reach specific cells and tissues outside the liver.
BiotechDeep TechHealthtechHatfield, US
Lauren Kaskiel(Executive Officer)inRobert C. Getts(Executive Officer)Brian McVeigh(Executive Officer, Director)in
BoardDmitry Kuzmin(Director)Victor Stone(Director)Edward Mathers(Director)
Co-investorsNew Enterprise Associates (NEA)4BIO CapitalHatteras Venture PartnersJDRF T1D FundNorthpond VenturesTakeda Ventures+1 more
Intermountain Health is a healthcare provider offering primary, pediatric, and specialty care services to patients, with a focus on preventive care and wellness.
Digital HealthHealthtech
Co-investorsEPIC VENTURESMerck Global Health Innovation Fund
Ember Life Sciences applies its temperature-control heating and cooling technology to healthcare logistics through the Ember Cube, a self-refrigerated, cloud-based shipping box with real-time location tracking and temperature monitoring for cold-chain payloads at 2°C–8°C.
HealthtechIoTLogistics & Supply ChainWestlake Village, US
Clayton Alexander(Executive Officer, Director)Brian Bejarano(Executive Officer)inAnn Marie Hyllengren(Executive Officer)
BoardMichael Kaufmann(Director)Timothy White(Director)James DeNaut(Director)
Co-investorsCarrier VenturesSea Court CapitalTDF Ventures
EnClear Therapies is a bio/med-tech company developing the EnTrega CSF platform, focused on cerebrospinal fluid-related therapies.
BiotechDigital HealthHealthtechMedical DevicesCambridge, US
Anthony DePasqua(Executive Officer, Director)inKevin Kalish(COO)inMarcie Glicksman(VP Biology)inWilliam Gormley(CMO)Jason Camm(Director)Kasper Roet(Director)in
Co-investors20/20 HealthCare Partners LLCDolby Family VenturesFlucas VenturesTachyon VenturesVU Venture PartnersBioverge+1 more
Gandeeva Therapeutics uses AI, machine learning, and atomic-resolution cryo-EM imaging to map druggable protein interactions and design molecular glues that bind at specific protein interfaces.
AI & Machine LearningBiotechDeep TechDigital Health
Sriram Subramaniam(Founder)in
Co-investorsAir Street CapitalLux CapitalObvious VenturesAmplitude Venture CapitalLeaps by Bayer
Genome Medical provides telehealth-enabled genetic services, including genetic counseling, genetic testing, and clinical trial matching, with a focus on individuals with rare conditions.
BiotechDigital HealthHealthtechSouth San Francisco, US
Lisa Alderson(Executive Officer, Director)inRandal Scott(Director)Jill Davies(Executive Officer, Director)inElizabeth Moreno(Executive Officer)inMark Sylvester(Chief Financial Officer)inAndrew Warner(Vice President, Product)in
Co-investorsAlumni VenturesAvestria VenturesCanaan PartnersDreamers VCEcho Health VenturesGV (Google Ventures)+11 more
HealthtechCambridge, US
COLIN HILL(Executive Officer, Director)inIYA KHALIL(Executive Officer)inTHOMAS NEYARAPALLY(Executive Officer)MARK POTTLE(Executive Officer)inCAROL MCCALL(Executive Officer)inBRUCE CHURCH(Executive Officer)in
Co-investorsAlexandriaEcho Health Ventures
BiotechRichmond, US
Michael D. Grisham(Chief Executive Officer)in
Co-investorsVensana Capital
OLG Machinery, founded in 2008, trades new and certified used industrial spare parts and machinery, serving U.S. companies operating across North and South America with a focus on Mexico.
Advanced ManufacturingB2B MarketplacesLogistics & Supply Chain
Co-investorsOxford Investment Opportunity Network (OION)Ally Bridge GroupAltium CapitalDroia VenturesFrazier Healthcare PartnersNovo Holdings+2 more
Hummingbird Bioscience is a precision biotherapeutics company developing a pipeline of novel targeted therapies for cancer, using proprietary drug discovery technologies and platforms.
AI & Machine LearningBiotechDeep TechHealthtech
Piers Ingram(Chief Executive Officer, Co-Founder, Executive Director)inJerome Boyd-Kirkup(Chief Scientific Officer, Co-Founder)inKonrad Paszkiewicz(Chief Technology Officer)inKwek Kon Yew(Chief Medical Officer)Dipti Thakkar(Chief Operating Officer)in
Co-investorsAltium CapitalClavystBioDecheng CapitalDroia VenturesFrazier Life SciencesKiwoom Investment+6 more
A pharmaceutical company that develops medicines and vaccines, with research pipelines and clinical trials aimed at new treatments.
BiotechHealthtech
Co-investorsFrazier Life SciencesHighlight CapitalMRL Ventures FundXeraya CapitalBlackRockBlackstone Life Sciences+5 more
Portfolio company acquired by Novo Nordisk for $1.1B USD.
Co-investorsAmorChemGenesys CapitalJDRF T1D FundNew Enterprise Associates (NEA)Tarnagulla VenturesadMare BioInnovations+2 more
Kernal Bio is a synthetic biology company developing selective mRNA drugs to treat serious illnesses, with a focus on cancer therapeutics and improving patient outcomes.
AI & Machine LearningBiotechHealthtechMedical DevicesBoston, US
Yusuf Erkul(Founder)inJeff Ozdemir(Founder)inBurak Yilmaz(Founder)inCatherine Moroski(Executive Officer, Director)inOguzhan Yilmas(Director)Burak YILMAZ(Founder)in
Co-investorsAsymmetry VenturesCivilization Ventures Management, LlcFoundersX VenturesHOF CapitalHummingbird VenturesSAV (Scale Asia Ventures)+13 more
Mindset Medical develops medical-grade software that uses remote photoplethysmography (rPPG) and deep learning to measure vital signs such as heart rate and respiratory rate through the camera on a patient's own smartphone, tablet, or computer.
AI & Machine LearningDigital HealthHealthtechMedical DevicesPhoenix, US
Mark L. Whitehouse(Executive Officer)inMitchell A. Foster(Executive Officer, Director, Promoter)Nicholas Theodore(Director)Joel Barthelemy(Director)
BoardJAMES GOULKA(Director)inBRIAN BURNS(Director)in
Co-investorsGrayhawk CapitalAZ Venture Capital Inc.NOVA PrimeQuesta CapitalXcellerant Ventures
QurAlis develops precision therapies for amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases by targeting specific disease-causing genetic drivers and molecular mechanisms.
BiotechDeep TechMedical DevicesCambridge, US
Kevin Eggan(Founder, QurAlis; Group Vice President, Head of Research and Early Development, BioMarin Pharmaceutical)inRoet(Co-founder)Woolf(Co-founder)Kasper Roet(Founder, Chief Executive Officer)inShafique Virani(Executive Officer)inJason Brown(Mr. Brown is the Chief Financial Officer of the Issuer.)in
Co-investorsALS Investment FundDolby Family VenturesDroia VenturesInkefMC Healthcare VenturesMission Biocapital+8 more
Develops programmable mRNA therapies that last longer and target cells more precisely for cancer and other diseases.
BiotechBoston, US
Tasuku Kitada(Executive Officer, Director, Promoter)inJacob Becraft(Executive Officer, Director, Promoter)inSamta Kundu(Executive Officer)in
BoardJeb Keiper(Director)inAla Alenazi(Director)inPegah Ebrahimi(Director)in
Co-investorsJIC Venture Growth InvestmentsKinnevikPlayground GlobalANRIFPVICONIQ+3 more
Strand is a clinical-stage biotechnology company developing programmable mRNA therapeutics for cancers and autoimmune diseases.
AI & Machine LearningBiotechMedical DevicesBoston, US
Jacob Becraft(CEO, Co-Founder)inTasuku Kitada(President, Head of R&D, Co-founder)inRon Weiss(Scientific Co-founder)inDarrell J. Irvine(Scientific Co-founder)inPrashant Nambiar(Chief Scientific Officer)Ethan Cash(Senior Vice President, Head of Portfolio Management and Program Development)in
Co-investorsAtinum Investment Co. Ltd.FPVLG Technology VenturesPlayground GlobalPotentum PartnersAlix Ventures+5 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Akili Interactive LabsEmber TechnologiesImago BioSciences, Inc.Khan Academy’s online learning websitesLabXchange
Exits · 8
5 IPOs · 3 acquisitions · showing 7BioAge LabsNASDAQ: BIOAGenerate BiomedicinesNASDAQ: GENBNeumora TherapeuticsNASDAQ: NMRANkarta, Inc.NASDAQ: NKTXSenti BiosciencesNASDAQ: SNTIImagoacq. by MerckInversagoacq. by Novo Nordisk
Portfolio news
latest coverage across their companiesEmber LifeSciences · prnewswire.com · May 27, 2026
Cartography Biosciences · finsmes.com · May 7, 2026
Mindset Medical · finsmes.com · Oct 9, 2025
Frequently asked questions
- How many investments has Amgen Ventures made?
- Amgen Ventures has 32 tracked investments, 8 of which have exited, including 5 dated in the last 24 months.
- What stage does Amgen Ventures invest at?
- Amgen Ventures invests at the Seed, Series A, Series B, Series C, Late Stage stages.
- What is Amgen Ventures's typical check size?
- Amgen Ventures typically writes checks of $1M – $3M.
- What sectors does Amgen Ventures focus on?
- Amgen Ventures focuses on Biotech, Healthtech.
- Where is Amgen Ventures located?
- Amgen Ventures is headquartered in Thousand Oaks, US.
Media · Podcasts & interviews
from their channelBrooke's Story: Overcoming B-Cell Acute Lymphoblastic Leukemia | Amgen
Amgen
IgG4-RD Explained: From Delayed Diagnosis to Improving Care
Amgen
AI in Drug Discovery: How Scientists are Leveraging Technology in Biotech Research
Amgen
Images
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
EDBI is the investment platform of Singapore's Economic Development Board and Enterprise Singapore, focusing on high-growth technology companies expanding into Singapore and Asia.
Founders Fund is a venture capital firm that backs technology companies building transformative products.
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.
.png)
General Catalyst is a venture capital firm operating as a partnership focused on company building and accelerating the growth of the businesses it backs.